Vaccine Dilemma

Covaxin is not in the Emergency Use Listing of WHO. Those who used covaxin for vaccination in India will not be able to travel to America and Europe atleast for now. Those with Covishield can. However efficacy of Covishield against the B.1.617.2 strain is only 60% so if u go to UK with Covishield and get infected it will be difficult for you. Covaxin efficacy against B.1.617.2 is unknown. more  

different types of viruses will come next 5 years more  
Abhi ki priority is Jaan bachana. Just get whatever vaccine you can. Itna lamba sochne ka abhi time nahin hai. more  
Covaxin is made by Bharat Biotech + ICMR so they should be showing adequate evidence to have it acceptable by WHO unless there is some political angle at play (China and WHO etc ) ??? Lancet of UK has accepted the findings in support of the Covaxin so even WHO should do it. more  
As per a TV news channel, Govt. of India as well as the manufacturers have taken the issue with WHO. more  
Please provide the official source that those who had covaxin in India will not be able to travel to America and Europe more  
Post a Comment

Related Posts

    • New Covid vaccines

      https://www.localc...

      By Sudesh Rai
      /
    • Covid is the trigger

      Covid isn’t a single event. It’s a trigger. It triggers new medical conditions. Preexisting conditions are exacerbated. It reactivates latent viruses. You age decades. Dysfunctional imm...

      By Anita Gupta
      /
    • Long Covid symptoms (neurological)

      Most common symptoms of the post-COVID-19 neurologic syndrome reported from 3,762 participants were as follows. LocalCircles must check with people with long covid in India as to what they are expe...

      By Malvika N
      /
    • The only race is of survival

      My close friend (40) who died this week in Melbourne had covid 3 times. The first time wasn’t so bad, the second one knocked him around pretty badly, and the third time he died of it. We&rsqu...

      By Irene Willems
      /
    • Events happening

      Whether it is business or social events, they are happening across the country though cases are rising. Business media houses are organising them. Why is it that the desire to make money is so much...

      By Sangita Baruah
      /
    • By Nikita Goyal
      /
    • Supreme Court says vaccine not mandatory

      The Supreme Court today held so as no substantial data has been produced on record to show that the risk of transmission of COVID-19 virus from the unvaccinated persons are higher than from vaccina...

      By Shailesh Deshmukh
      /
    • Science vs Politics

      With BA.4 and BA.5 on the horizon and liver problems on the rise, we are soon to have an epic battle of science vs. politics in most countries around the world. Most politicians have dr...

      By Shikha Mittal
      /
    • Discipline

      Devil's advocate argument is that government could be wanting to make wearing a mask a habit among people, and those driving around have a greater responsibility, especially the affluent, in this c...

      By Ashish Rai
      /
    • Vaccines not much helpful post Omicron infections

      The additive benefit of vaccination with Omicron infection for neutralizing antibodies as compared with infection alone is much lower anticipated protection across all variants, including Omicron i...

      By Harsimran Kaur
      /
    • Open up booster for 45+ instead of 60+

      Last year in March, when the vaccination was opened up for the common citizens, it was for the age of 45 and above. All those above 45 (including 60+) living in a house, who wanted to get vaccinate...

      By Padmanabhan G
      /
Share
Enter your email and mobile number and we will send you the instructions

Note - The email can sometime gets delivered to the spam folder, so the instruction will be send to your mobile as well

All My Circles
Invite to
(Maximum 500 email ids allowed.)